I agree. Bupa action takes this into new territory and confirmation for others to follow over time. Might take awhile for others to realise OSL has come of age at last & for share price to move imo. Institutions will be doing more research before buying over time. DYOR
Any other positives I've missed do please tell me dear readers so I can post on LinkedIn all the milestone positives for this company. Strangely enough some of my readers do take notice but i dont discuss share price.
Ann: Bupa UK Approves Reimbursement for OncoSil in the UK, page-23
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
0.005(0.47%) |
Mkt cap ! $20.23M | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.08 | $1.07 | $498.1K | 465.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 531 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 8485 | 2 |
View Market Depth
| Last trade - 13.18pm 01/08/2025 (20 minute delay) ? |
| OSL (ASX) Chart |